| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A protective chimeric antibody to tick-borne encephalitis virus
|
Baykov, Ivan K.
|
|
2014
|
32 |
29 |
p. 3589-3594
6 p.
|
artikel
|
| 2 |
Booster immune response in children 6–7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection
|
Díaz-Ortega, José-Luis
|
|
2014
|
32 |
29 |
p. 3680-3686
7 p.
|
artikel
|
| 3 |
Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care
|
Zimmerman, Richard K.
|
|
2014
|
32 |
29 |
p. 3656-3663
8 p.
|
artikel
|
| 4 |
Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation
|
Wibowo, Nani
|
|
2014
|
32 |
29 |
p. 3664-3669
6 p.
|
artikel
|
| 5 |
Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India
|
Hegde, Nagendra R.
|
|
2014
|
32 |
29 |
p. 3636-3643
8 p.
|
artikel
|
| 6 |
Editorial Board/Aims and Scope
|
|
|
2014
|
32 |
29 |
p. IFC-
1 p.
|
artikel
|
| 7 |
Effectiveness of typhoid vaccination in US travelers
|
Mahon, Barbara E.
|
|
2014
|
32 |
29 |
p. 3577-3579
3 p.
|
artikel
|
| 8 |
Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from two randomized trials
|
Van Damme, Pierre
|
|
2014
|
32 |
29 |
p. 3694-3705
12 p.
|
artikel
|
| 9 |
European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era
|
Torné, Adoración Navarro
|
|
2014
|
32 |
29 |
p. 3644-3650
7 p.
|
artikel
|
| 10 |
Evaluating the potential risks and benefits of infant rotavirus vaccination in England
|
Clark, Andy
|
|
2014
|
32 |
29 |
p. 3604-3610
7 p.
|
artikel
|
| 11 |
Heat-killed yeast protects diabetic ketoacidotic-steroid treated mice from pulmonary mucormycosis
|
Luo, Guanpingsheng
|
|
2014
|
32 |
29 |
p. 3573-3576
4 p.
|
artikel
|
| 12 |
IFN-?, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection
|
Roberts, Lydia M.
|
|
2014
|
32 |
29 |
p. 3595-3603
9 p.
|
artikel
|
| 13 |
Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults
|
Pan, Hong-Xing
|
|
2014
|
32 |
29 |
p. 3706-3712
7 p.
|
artikel
|
| 14 |
Oral vaccination and protection of striped skunks (Mephitis mephitis) against rabies using ONRAB®
|
Brown, L.J.
|
|
2014
|
32 |
29 |
p. 3675-3679
5 p.
|
artikel
|
| 15 |
Perceptions of personal belief vaccine exemption policy: A survey of Arizona vaccine providers
|
Haenchen, Steven D.
|
|
2014
|
32 |
29 |
p. 3630-3635
6 p.
|
artikel
|
| 16 |
Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: Extending the potential of broadly cross-protecting epitopes
|
Wibowo, Nani
|
|
2014
|
32 |
29 |
p. 3651-3655
5 p.
|
artikel
|
| 17 |
Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5
|
Lee, Jung-Ah
|
|
2014
|
32 |
29 |
p. 3617-3622
6 p.
|
artikel
|
| 18 |
Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines
|
Crafford, J.E.
|
|
2014
|
32 |
29 |
p. 3611-3616
6 p.
|
artikel
|
| 19 |
The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012
|
Turner, Nikki
|
|
2014
|
32 |
29 |
p. 3687-3693
7 p.
|
artikel
|
| 20 |
The epidemiology of varicella cases among children in Beijing's Fengtai District from 2008 to 2012
|
Zhang, Xue
|
|
2014
|
32 |
29 |
p. 3569-3572
4 p.
|
artikel
|
| 21 |
The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4+ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs
|
Commandeur, Susanna
|
|
2014
|
32 |
29 |
p. 3580-3588
9 p.
|
artikel
|
| 22 |
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
|
Alberca, Berta
|
|
2014
|
32 |
29 |
p. 3670-3674
5 p.
|
artikel
|
| 23 |
Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies
|
Taylor, Luke E.
|
|
2014
|
32 |
29 |
p. 3623-3629
7 p.
|
artikel
|
Tijdschrift beschrijving